Sodium valproate and 5-aza-2′-deoxycytidine differentially modulate DNA demethylation in G1 phase-arrested and proliferative HeLa cells

Cytometric assessment of CD133− and CD133+ and their cell cycle in

Sodium valproate (VPA) interactions with DNA and histones - ScienceDirect

DNA demethylation by 5-aza-2′-deoxycytidine is imprinted, targeted to euchromatin, and has limited transcriptional consequences, Epigenetics & Chromatin

DNA demethylation by 5-aza-2′-deoxycytidine is imprinted, targeted to euchromatin, and has limited transcriptional consequences, Epigenetics & Chromatin

PDF) Sodium valproate and 5-aza-2′-deoxycytidine differentially modulate DNA demethylation in G1 phase-arrested and proliferative HeLa cells

TET protein inhibitors: Potential and limitations - ScienceDirect

Evidence from clinical trials for the use of valproic acid in solid tumors: focus on prostate cancer

Sodium valproate and 5-aza-2′-deoxycytidine differentially modulate DNA demethylation in G1 phase-arrested and proliferative HeLa cells

Cancers, Free Full-Text

Sodium valproate and 5-aza-2′-deoxycytidine differentially modulate DNA demethylation in G1 phase-arrested and proliferative HeLa cells

Sodium Valproate Modulates the Methylation Status of Lysine Residues 4, 9 and 27 in Histone H3 of HeLa Cells

TET protein inhibitors: Potential and limitations - ScienceDirect

Frontiers Sodium Valproate-Induced Chromatin Remodeling

Genomic context of differentially methylated probes shows enrichment